Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.75 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.75 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | NT5E | P21589 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL27978292 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL51726 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL28609920 | 1.00 | CA5A (0.75) | CA5ACA5BBLMKDM4ETSHR | |
| Sulfuric Acid SCHEMBL6665125 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL452000 | 1.00 | CA5A (0.75) | CA5ACA5BBLMKDM4ETSHR | |
| Sulfuric Acid SCHEMBL196548 | 1.00 | CA5A (0.75) | CA5ACA5BBLMKDM4ETSHR | |
| Sulfuric Acid SCHEMBL6670714 | 1.00 | CA5A (0.75) | CA5ACA5BBLMKDM4ETSHR | |
| Sulfuric Acid SCHEMBL8996515 | 1.00 | CA5A (0.75) | CA5ACA5BBLMKDM4ETSHR | |
| Sulfuric Acid SCHEMBL66345 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL28285449 | 1.00 | CA5A (0.75) | CA5ACA5BBLMKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12305286-B2 | Metal sheet treatment method and metal sheet treated with this method | ARCELORMITTAL (LU) | 2025-05-20 | — | — | US | claimed |
| US-20240093375-A1 | Metal sheet treatment method and metal sheet treated with this method | ARCELORMITTAL (LU) | 2024-03-21 | — | — | US | claimed |
| EP-4045696-B1 | METAL SHEET TREATMENT METHOD AND METAL SHEET TREATED WITH THIS METHOD | ARCELORMITTAL (LU) | 2023-11-29 | — | — | EP | claimed |
| EP-4045696-A1 | METAL SHEET TREATMENT METHOD AND METAL SHEET TREATED WITH THIS METHOD | ArcelorMittal (LU) | 2022-08-24 | — | — | EP | claimed |
| CN-111133123-A | Method for treating metal plate and metal plate treated by the method | 安赛乐米塔尔公司 | 2020-05-08 | — | — | CN | claimed |
| CN-111094614-A | Method for treating metal plate and metal plate treated by the method | 安赛乐米塔尔公司 | 2020-05-01 | — | — | CN | claimed |
| US-12441751-B2 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | THE GENERAL HOSPITAL CORPORATION (US) | 2025-10-14 | — | — | US | disclosed |
| US-12305286-B2 | Metal sheet treatment method and metal sheet treated with this method | ARCELORMITTAL (LU) | 2025-05-20 | — | — | US | disclosed |
| CN-118420662-A | Process for preparing dialkylphosphinic salts and flame retardants | 菏泽奕普新材料有限公司 | 2024-08-02 | — | — | CN | disclosed |
| US-20240093375-A1 | Metal sheet treatment method and metal sheet treated with this method | ARCELORMITTAL (LU) | 2024-03-21 | — | — | US | disclosed |
| EP-4045696-B1 | METAL SHEET TREATMENT METHOD AND METAL SHEET TREATED WITH THIS METHOD | ARCELORMITTAL (LU) | 2023-11-29 | — | — | EP | disclosed |
| US-20230287030-A1 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | THE GENERAL HOSPITAL CORPORATION | 2023-09-14 | — | — | US | disclosed |
| US-11634448-B2 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | THE GENERAL HOSPITAL CORPORATION (US) | 2023-04-25 | — | — | US | disclosed |
| US-20170362266-A1 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | THE GENERAL HOSPITAL CORPORATION | 2017-12-21 | — | — | US | disclosed |
| WO-2017218796-A1 | METABOLIC LABELING AND MOLECULAR ENHANCEMENT OF BIOLOGICAL MATERIALS USING BIOORTHOGONAL REACTIONS | OTT HARALD C (US) | 2017-12-21 | — | — | WO | disclosed |
| EP-1259466-B1 | A METHOD FOR PROCESSING LIGNOCELLULOSIC MATERIAL | UNIV DENMARK TECH DTU (DK) | 2008-10-22 | — | — | EP | disclosed |
| US-6555350-B2 | Providing an aqueous slurry of the biomass material, heating in presence of oxygen; partial hydrolysis of cellulose and hemicellulose; ethanol fermentation; separating the ethanol; subjecting wastewater effluent to a treatment | FORSKNINGSCENTER RISO (DK) | 2003-04-29 | — | — | US | disclosed |
| US-20020192774-A1 | Method for processing lignocellulosic material | COBANK, ACB, AS ADMINISTRATIVE AGENT | 2002-12-19 | — | — | US | disclosed |
| EP-1259466-A1 | A METHOD FOR PROCESSING LIGNOCELLULOSIC MATERIAL | FORSKNINGSCENTER RISO (DK) | 2002-11-27 | — | — | EP | disclosed |
| WO-2001060752-A1 | A METHOD FOR PROCESSING LIGNOCELLULOSIC MATERIAL | Forskningscenter Risø (DK) | 2001-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11634448-B2 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | GALNT14, NEU4, CSGALNACT1 | CA5A 211/4885CA5B 399/4885BLM 4767/4885 |
| US-12441751-B2 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | GALNT14, NEU4, CSGALNACT1 | CA5A 211/4885CA5B 399/4885BLM 4767/4885 |
| US-20170362266-A1 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | GALNT14, NEU4, CSGALNACT1 | CA5A 211/4885CA5B 399/4885BLM 4767/4885 |
| US-20230287030-A1 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | GALNT14, NEU4, CSGALNACT1 | CA5A 211/4885CA5B 399/4885BLM 4767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.